Where are we with treatment options after first line in small cell lung cancer?—report of two opposite cases treated with CAPTEM regimen and possible perspectives

by Cortellini, Alessio, Dal Mas, Antonella, Cannita, Katia, Collina, Guido, Parisi, Alessandro, Pavese, Francesco, Porzio, Giampiero, Verna, Lucilla, Ficorella, Corrado
Published in J Thorac Dis (2018)

Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction...

by Bruera, Gemma, Massacese, Silvia, Pepe, Francesco, Malapelle, Umberto, Dal Mas, Antonella, Ciacco, Eugenio, Calvisi, Giuseppe, Troncone, Giancarlo, Simmaco, Maurizio, Ricevuto, Enrico
Published in Ther Adv Med Oncol (2019)

Platelet Concentration in Platelet-Rich Plasma Affects Tenocyte Behavior In Vitro

by Giusti, Ilaria, D'Ascenzo, Sandra, Mancò, Annalisa, Di Stefano, Gabriella, Di Francesco, Marianna, Rughetti, Anna, Dal Mas, Antonella, Properzi, Gianfranco, Calvisi, Vittorio, Dolo, Vincenza
Published 2014

Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation

by Napoleoni, Luca, Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Dal Mas, Antonella, Calvisi, Giuseppe, Venditti, Olga, Lanfiuti Baldi, Paola, Cocciolone, Valentina, Ricci, Alessandro, Ficorella, Corrado
Published in Bioengineering (Basel) (2019)

Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of...

by Bruera, Gemma, Cannita, Katia, Di Giacomo, Daniela, Lamy, Aude, Troncone, Giancarlo, Dal Mas, Antonella, Coletti, Gino, Frébourg, Thierry, Sabourin, Jean Christophe, Tosi, Mario, Ficorella, Corrado, Ricevuto, Enrico
Published 2012

Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice

by Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Lanfiuti Baldi, Paola, Venditti, Olga, D’Orazio, Carla, Dal Mas, Antonella, Calvisi, Giuseppe, Giordano, Aldo V, Vicentini, Vincenzo, Vicentini, Roberto, Felicioni, Lara, Marchetti, Antonio, Buttitta, Fiamma, Russo, Antonio, Ficorella, Corrado
Published in Onco Targets Ther (2019)

Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations

by Cocciolone, Valentina, Cannita, Katia, Tessitore, Alessandra, Mastroiaco, Valentina, Rinaldi, Lucia, Paradisi, Stefania, Irelli, Azzurra, Baldi, Paola Lanfiuti, Sidoni, Tina, Ricevuto, Enrico, Dal Mas, Antonella, Calvisi, Giuseppe, Coletti, Gino, Ciccozzi, Antonietta, Pizzorno, Laura, Resta, Valter, Bafile, Alberto, Alesse, Edoardo, Ficorella, Corrado
Published in Oncotarget (2018)

External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale

by Terrenato, Irene, Arena, Vincenzo, Pizzamiglio, Sara, Pennacchia, Ilaria, Perracchio, Letizia, Buglioni, Simonetta, Ercolani, Cristiana, Sperati, Francesca, Costarelli, Leopoldo, Bonanno, Elena, Baldini, Daniela, Candia, Silvia, Crescenzi, Anna, Dal Mas, Antonella, Di Cristofano, Claudio, Gomes, Vito, Grillo, Lucia Rosalba, Pasquini, Paola, Pericoli, Maria Nicoletta, Ramieri, Maria Teresa, Di Stefano, Domenica, Ruco, Luigi, Scarpino, Stefania, Vitolo, Domenico, d’Amati, Giulia, Paradiso, Angelo, Verderio, Paolo, Mottolese, Marcella
Published 2013